With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting the Epigenome of Diffuse Intrinsic Pontine Glioma||The Johns Hopkins University School of Medicine / Sama Ahsan, MD||Young Investigator Grants||2014||Maryland|
|Targeting Aberrant Hh Signaling with BET Bromodomain Inhibition as a Novel Therapeutic Strategy Against MB and DIPG||Lucile Packard Children's Hospital at Stanford University School of Medicine / Yujie Tang, PhD||Young Investigator Grants||2014||California|
|Targeting the Thymic Stromal Lymphopoeitin Receptor Signaling Axis to Reduce Relapse of High Risk Pediatric Acute Lymphoblastic Leukemia||National Cancer Institute / Christopher Chien, PhD||Young Investigator Grants||2014||Maryland|
|Identification of Resistance Mechanisms and Novel Therapeutic Strategies in Tyrosine Kinase Inhibitor Resistant FLT3/ITD Acute Myeloid Leukemia||Fred Hutchinson Cancer Research Center / Katherine Tarlock, MD||Young Investigator Grants||2014||Washington|
|APOBEC3 in Pediatric Leukemia: a Biomarker for Sensitivity to PARP Inhibition?||Children's Hospital of Philadelphia / Abby Green, MD||Young Investigator Grants||2014||Pennsylvania|
|Identifying Drug Resistant Mutations in Ph-like Acute Lymphoblastic Leukemia||University of California San Francisco / Mignon Loh, M.D.||Innovation Grants||2014||California|
|Role of LMO1 in Neuroblastoma Initiation and Maintenance: Analysis in the Zebrafish model of Childhood Neuroblastoma||Dana-Farber Cancer Institute / Thomas Look, M.D.||Innovation Grants||2014||Massachusetts|
|Correction of Hematopoietic Defects in Down Syndrome by Chromosome 21 Silencing||University of Massachusetts Medical School / Peter Newburger, M.D.||Innovation Grants||2014||Massachusetts|
|Trib2 in the Pathogenesis of T-ALL||University of Pennsylvania / Warren Pear, M.D., Ph.D.,||Innovation Grants||2014||Pennsylvania|
|Targeting Tumor Suppressor MicroRNAs in Pediatric Acute Lymphoblastic Leukemia||The Johns Hopkins University School of Medicine / Linda Resar, M.D.||Innovation Grants||2014||Maryland|